Algonist Biotechnologies is developing small molecule therapeutics that provide pain relief comparable to opioids without the risk of addiction. This addresses the significant unmet medical need for effective treatments for the 1.5 billion people suffering from chronic pain globally.

Brainhero offers a CE-certified EEG-mediated neurofeedback training device designed for children with autism and ADHD, enabling personalized therapy that adapts to individual symptoms. This hybrid solution combines clinical and at-home treatment, providing measurable insights to track progress and enhance therapeutic effectiveness.

The startup develops real-time food recognition technology using artificial intelligence to enhance restaurant operations through image recognition and classification. This technology automates processes such as checkout and object tracking, enabling restaurants to improve efficiency and increase revenue.

Eyeson Oneview provides a real-time omnimedia communication platform that integrates live data streams from drones, body cameras, and other sources into a synchronized, encrypted virtual situation room. This technology enhances situational awareness and decision-making for defense and emergency response teams operating in complex environments with limited bandwidth and connectivity.

Greenpass offers a software platform that utilizes AI-driven analytics and digital twin technology to assess and certify climate resilience in real estate assets and portfolios. The platform enables real estate stakeholders to comply with ESG and EU regulations while optimizing investment returns and minimizing climate-related risks.